Citizens Maintains Market Outperform on Stereotaxis, Lowers Price Target to $3
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Citizens analyst Daniel Stauder maintains Stereotaxis (AMEX:STXS) with a Market Outperform and lowers the price target from $4 to $3.
Citizens analyst Daniel Stauder maintains Stereotaxis (AMEX:STXS) with a Market Outperform and lowers the price target from $4 to $3.